PPTA and Six Organizations Oppose NJ Tax on Clotting Factor (June 27, 2013)
ANNAPOLIS, MD—The Plasma Protein Therapeutics Association (PPTA) opposes New Jersey Senate Bill 2132 that imposes a new tax on therapies used to treat bleeding disorders such as hemophilia.
- Created on .